Disseminated intravascular coagulation

17,652 views 24 slides Jul 06, 2019
Slide 1
Slide 1 of 24
Slide 1
1
Slide 2
2
Slide 3
3
Slide 4
4
Slide 5
5
Slide 6
6
Slide 7
7
Slide 8
8
Slide 9
9
Slide 10
10
Slide 11
11
Slide 12
12
Slide 13
13
Slide 14
14
Slide 15
15
Slide 16
16
Slide 17
17
Slide 18
18
Slide 19
19
Slide 20
20
Slide 21
21
Slide 22
22
Slide 23
23
Slide 24
24

About This Presentation

.


Slide Content

Disseminated intravascular coagulation RATHEESH R.L

Disseminated intravascular coagulation  ( DIC ), also known as  disseminated intravascular coagulopathy  , is a pathological process characterized by the widespread activation of the  clotting  cascade that results in the formation of blood clots in the  small blood vessels  throughout the body.

etiology Acute DIC Sub acute DIC Chronic DIC

Acute DIc Septicemia Hemolytic processes * Transfusion of mismatched blood * Acute hemolysis from infection * Amniotic fluid embolism * Septic abortion Malignancies * Acute leukemia * Lymphoma

Acute Dic … Tissue damage * Extensive burns and trauma * Severe head injury * Transplant rejections * Snake bite * Glomerulonephritis

Sub acute DIC Malignant disease * Myeloproliferative malignancies * Metastatic cancer Obstetric * Retained dead fetus

Chronic dic Liver disease Systemic lupus erythematosus Localized malignancy

pathophysiology Etiologic factors Normal coagulation mechanism gets enhanced Abundant intravascular thrombin is produced Catalyses the conversion of fibrinogen to fibrin and enhances platelet aggregation Wide spread fibrin and platelet deposition in capillaries and arterioles

pathophysiology Thrombosis Multiorgan failure Clotting inhibitory mechanisms such as anti thrombin III and protein C are depressed Excesssive clotting activates the fibrinolytic system Breaks down the newly formed clot

pathophysiology creating fibrin split products Inhibit normal blood clotting Accumulation of fibrin split products and decreased clotting factors Blood loses its ability to clot Predispose the patient to hemorrhage

Clinical manifestations Bleeding manifestations Thrombotic manifestations

Bleeding manifestations Result from depletion of platelets and coagulation factors as well as clot lysis and formation of fibrin split products Respiratory: Tachypnea , Hemoptysis , orthopnea Cardiovascular : Tachycardia, Hypotension GI : Upper and lower GI bleeding, abdominal distension, bloody stools GU : Hematuria

Bleeding manifestations Neurologic changes: vision changes, dizziness, headache, changes in mental status, irritability Musculoskeletal : Bone and joint pain

Thrombotic manifestations Result of fibrin or platelet deposition in the microvasculature Integumentary : Cyanosis, Ischemic tissue necrosis, hemorrhagic necrosis Respiratory: Tachypnea , dyspnea , pulmonary emboli, acute respiratory distress syndrome

Cardiovascular: Venous distension GI : Abdominal pain, paralytic ileus Renal: kidney damage, oliguria kidney failure

Diagnostic measures History collection and physical examination Blood studies Bone marrow aspiration and biopsy ultrasound

Blood studies Prothrombin time : prolonged Partial thromboplastin time : prolonged Thrombin time : prolonged Fibrinogen : reduced Platelets : reduced

Fibrin split products : elevated Factor assays (V, VII, VIII, X, XIII) : reduced D- Dimers : elevated Protein S: reduced Protein C : reduced Blood smear examination : fragmented erythrocytes

management Platelet and plasma transfusion Coagulation factor concentrates such as prothrombin complex Repeated measurements of activated partial thromboplastin time and prothrombin time

Anticoagulant therapy * heparin * anti thrombin III * hirudin * epsilon amino caproic acid

NURSING MANAGEMENT Monitor vital signs Assess and document the extent of hemorrhage and thrombosis Correct hypovolemia Administer basic hemostatic procedures when indicated Provide psychological support

Nursing diagnosis Ineffective tissue perfusion related to bleeding and diminished blood flow Deficient fluid volume related to active fluid volume loss( hemorrhage) Impaired oral mucous membrane related to low platelet count

Anxiety related to change in the health status, threat of death Deficient knowledge regarding disease process, treatments, self care and discharge needs related to lack of previous exposure
Tags